Atovaquone And Proguanil Hydrochloride
Product Images NDC 68071-3473

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Atovaquone And Proguanil Hydrochloride (NDC 68071-3473). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 3473 2)

Atovaquone 250mg and Proguanil Hydrochloride 100mg tablets packaged by NuCare Pharmaceuticals, Inc. The label indicates a package size of 24 tablets with prescription-only status. Includes usage instructions, manufacturer details, barcodes, lot numbers, expiration dates, and storage instructions at controlled room temperature (68-77°F).*

FDA Label Image

Atovaquonestructure (Atovaquonestructure)

Chemical structure of the active ingredient Atovaquone. The diagram shows the molecular framework including a chlorophenyl group and quinone moiety recognizable in its ring structures and substituents.*

FDA Label Image

Logo (Logo)

FDA Label Image

Proguanilstructure (Proguanilstructure)

Chemical structure of Atovaquone and Proguanil Hydrochloride displaying the molecular framework with chlorine, nitrogen, carbon, hydrogen atoms, and hydrochloride (HCl) indicated.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.